CRIMALDDI: platform technologies and novel anti-malarial drug targets

被引：0
|
作者：
Henri Vial
Donatella Taramelli
Ian C Boulton
Steve A Ward
Christian Doerig
Kelly Chibale
机构：
[1] Université Montpellier 2,Centre National de la Recherche Scientifique, UMR 5235
[2] Università di Milano,Dipartmento di Scienze Farmacologiche e Biomolecolari
[3] TropMed Pharma Consulting Ltd,Department of Microbiology
[4] Liverpool School of Tropical Medicine,Department of Chemistry
[5] School of Biomedical Sciences,undefined
[6] Monash University,undefined
[7] University of Cape Town,undefined
来源：
Malaria Journal | / 12卷
关键词：
CRIMALDDI; Malaria; Drug discovery; Research agenda; Novel targets; Enabling technologies; Prioritization;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The Coordination, Rationalization, and Integration of antiMALarial drug Discovery & Development Initiatives (CRIMALDDI) Consortium, funded by the EU Framework Seven Programme, has attempted, through a series of interactive and facilitated workshops, to develop priorities for research to expedite the discovery of new anti-malarials. This paper outlines the recommendations for the development of enabling technologies and the identification of novel targets.
引用
收藏
相关论文
共 50 条
  • [1] CRIMALDDI: platform technologies and novel anti-malarial drug targets
    Vial, Henri
    Taramelli, Donatella
    Boulton, Ian C.
    Ward, Steve A.
    Doerig, Christian
    Chibale, Kelly
    MALARIA JOURNAL, 2013, 12
  • [2] Protein transport mechanisms in Plasmodium falciparum as novel anti-malarial drug targets
    Rawat, K.
    Kibria, K. M.
    Panchal, M.
    Dacks, J. B.
    Mohmmed, A.
    Tuteja, R.
    Malhotra, P.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2015, 20 : 120 - 120
  • [3] CRIMALDDI: a prioritized research agenda to expedite the discovery of new anti-malarial drugs
    Ward, Steve A.
    Boulton, Ian C.
    MALARIA JOURNAL, 2013, 12
  • [4] CRIMALDDI: a prioritized research agenda to expedite the discovery of new anti-malarial drugs
    Steve A Ward
    Ian C Boulton
    Malaria Journal, 12
  • [5] A NEW ANTI-MALARIAL DRUG
    HOOPER, D
    NATURE, 1946, 157 (3978) : 106 - 106
  • [6] CRIMALDDI: a co-ordinated, rational, and integrated effort to set logical priorities in anti-malarial drug discovery initiatives
    Ian C Boulton
    Solomon Nwaka
    Ian Bathurst
    Michael Lanzer
    Donatella Taramelli
    Henri Vial
    Christian Doerig
    Kelly Chibale
    Steve A Ward
    Malaria Journal, 9
  • [7] In search of suitable protein targets for anti-malarial and anti-dengue drug discovery
    Phuong Thuy Viet Nguyen
    Giang Le Tra Nguyen
    Oanh Thi Dinh
    Cuong Quoc Duong
    Nguyen, Lam H.
    Truong, Thanh N.
    JOURNAL OF MOLECULAR STRUCTURE, 2022, 1256
  • [8] Anti-malarial drug formulations and novel delivery systems: A review
    Murambiwa, P.
    Masola, B.
    Govender, T.
    Mukaratirwa, S.
    Musabayane, C. T.
    ACTA TROPICA, 2011, 118 (02) : 71 - 79
  • [9] CRIMALDDI: a co-ordinated, rational, and integrated effort to set logical priorities in anti-malarial drug discovery initiatives
    Boulton, Ian C.
    Nwaka, Solomon
    Bathurst, Ian
    Lanzer, Michael
    Taramelli, Donatella
    Vial, Henri
    Doerig, Christian
    Chibale, Kelly
    Ward, Steve A.
    MALARIA JOURNAL, 2010, 9
  • [10] PALUDRINE - A NEW ANTI-MALARIAL DRUG
    不详
    NATURE, 1945, 156 (3968) : 596 - 597
12345